Peter Hohenberger

Mannheim, BW 68135, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 216 publications

Selective Internal Radiation Therapy (SIRT) for SDH-Deficient GIST Demonstrates Encouraging Durable Response Rates: An International Multicenter Case Series.

Selective Internal Radiation Therapy (SIRT) for SDH-Deficient GIST Demonstrates Encouraging Durable Response Rates: An International Multicenter Case Series.

Journal: Cancers
Published: July 09, 2026

Prognostic Factors and Outcomes for Post-Radiation Sarcoma-A Systematic Review and Meta-Analysis.

Prognostic Factors and Outcomes for Post-Radiation Sarcoma-A Systematic Review and Meta-Analysis.

Journal: Cancers
Published: July 06, 2026

Sarcomas: Research on Ultrarare Subtypes Gains Ground.

Sarcomas: Research on Ultrarare Subtypes Gains Ground.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: May 29, 2026

Nilotinib revisited in GIST: Salvage use in patients with severe imatinib toxicity.

Nilotinib revisited in GIST: Salvage use in patients with severe imatinib toxicity.

Journal: The oncologist
Published: March 27, 2026

Evaluating reasoning models for therapy recommendations in gastrointestinal stromal tumors: expert and LLM-based evaluations of OpenAI o1 and DeepSeek-R1.

Evaluating reasoning models for therapy recommendations in gastrointestinal stromal tumors: expert and LLM-based evaluations of OpenAI o1 and DeepSeek-R1.

Journal: Journal of cancer research and clinical oncology
Published: February 27, 2026

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

Journal: JAMA oncology
Published: February 26, 2026

The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa Study.

The Health-Related Quality of Life of German Desmoid Patients: Results from the PROSa-DES and PROSa Study.

Journal: Cancers
Published: February 23, 2026

Historical evaluation of clinical outcomes and safety following isolated limb perfusion for unresectable melanoma: Real-world data from the Mannheim Cancer Center.

Historical evaluation of clinical outcomes and safety following isolated limb perfusion for unresectable melanoma: Real-world data from the Mannheim Cancer Center.

Journal: Therapeutic advances in medical oncology
Published: February 22, 2026

Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group.

Treatment of retroperitoneal sarcoma in Germany between 2000 and 2022: a retrospective analysis from the German Cancer Registry Group.

Journal: Journal of cancer research and clinical oncology
Published: February 16, 2026

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026

Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

Predicting Clinical Sensitivities of PDGFRA Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment.

Journal: Cancer research communications
Published: January 30, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Journal: Cancer research
Published: January 12, 2026
Showing 1-12 of 216

Last Updated: 09/26/2026